Criterium, Inc.
Clinical trials sponsored by Criterium, Inc., explained in plain language.
-
Blood test could spot hidden breast cancer and guide Life-Saving Follow-Up therapy
Disease control Recruiting nowThis study tests whether a simple blood test that finds tumor DNA can help doctors decide when to give extra treatment to women with a high-risk type of breast cancer (ER+/HER2-). About 70 women who have finished initial hormone therapy but are still at risk will be monitored. If…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 16, 2026 22:33 UTC
-
New drug combo aims to slow advanced colorectal cancer
Disease control Recruiting nowThis study tests whether adding a second drug (TAS-102) to the standard drug fruquintinib helps people with advanced colorectal cancer live longer without their cancer growing. About 120 adults whose cancer has not responded to prior treatments will be randomly assigned to receiv…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug cocktail aims to tame tough breast cancer
Disease control Recruiting nowThis study tests a combination of three drugs (tucatinib, eribulin, and trastuzumab) in 30 people with advanced HER2+ breast cancer that has not responded to prior treatments. The goal is to see if the combo can shrink tumors or slow cancer growth while monitoring side effects. P…
Phase: PHASE2 • Sponsor: Criterium, Inc. • Aim: Disease control
Last updated May 15, 2026 11:54 UTC